Abstract
Among All of Us participants, the prevalence of inflammatory bowel disease is similar to past estimates (around 1%) and is highest among White, non-Hispanic, college-educated participants. Medication treatment patterns differ significantly based on ethnicity, education, and income status.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
